📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: SSI Strategy

1.1 - Company Overview

SSI Strategy Logo

SSI Strategy

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of life sciences consulting combining business, medical, clinical, and pharmacovigilance expertise across the product lifecycle, including pre-clinical target identification, regulatory compliance, toxicology and FIH preparation; early development infrastructure and teams; late-stage evidence for regulatory approval, payer acceptance and patient outcomes; commercialization (launch and post-market support); and AI solutions via Metalmind.

Products and services

  • Late Development & Submission: SSI Strategy develops regulatory-grade evidence for regulatory approval, payer acceptance, and patient outcomes, architecting submission strategies during late-stage development
  • Early Development: SSI Strategy transforms assets into clinical-stage entities by establishing custom-engineered trial infrastructure and multidisciplinary teams for early studies to enable initial clinical execution
  • Pre-Clinical: SSI Strategy identifies targets and ensures regulatory-compliant pre-clinical standards, addressing toxicology concerns and preparing assets for First-in-Human trials through targeted risk assessment and readiness planning

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to SSI Strategy

Minafin Logo

Minafin

HQ: France Website
  • Description: Provider of fine chemicals for life sciences and high tech, developing and manufacturing active ingredients, organic intermediates, and specialty chemicals. Offers APIs (patented, generic, HPAPIs), cosmetic and agricultural ingredients, bio-based solvents and fine chemicals, highly reactive chemistry for complex synthesis, process scale-up, high-pressure chemistry, and niche polymers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Minafin company profile →
Orgenesis Logo

Orgenesis

HQ: United States Website
  • Description: Provider of point-of-care platforms, technologies, and networks to develop, produce, and distribute advanced cell and gene therapies, including a novel diabetes treatment that converts liver cells into functional insulin-producing cells. Offers POCare Platform, Therapies, Technologies, and a global POCare Network to lower costs and accelerate market access.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Orgenesis company profile →
Build Clinical Logo

Build Clinical

HQ: United States Website
  • Description: Provider of a HIPAA-compliant platform and services to accelerate clinical research patient recruitment, including custom digital ads on search engines, health websites, and social media; study-specific landing pages; pre-screen questionnaires; real-time participant data management; monthly analytics reporting; and 24/7 support.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Build Clinical company profile →
Project Farma Logo

Project Farma

HQ: United States Website
  • Description: Provider of healthcare consulting services to pharmaceutical and medical device manufacturers across the supply chain, including GMP-compliant cell and gene therapy facility builds using modular, bioreactor and single-use technologies; business and manufacturing strategy; turnkey capital projects and project management; validation for GMP/GLP/GCP; quality, regulatory and compliance for ISO/GMP; and engineering and automation solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Project Farma company profile →
Locust Walk Logo

Locust Walk

HQ: United States Website
  • Description: Provider of strategic partnering and M&A services, facilitating licensing and acquisition deals in the USA, Europe, Japan, and China. Offers capital raising and underwriting, including private placements, IPO advisory, and SPAC advisory. Delivers strategy consulting and analytics for partnering, M&A, and fundraising. Conducts rigorous due diligence via internal committee and external scientific advisory board.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Locust Walk company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for SSI Strategy

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to SSI Strategy

2.2 - Growth funds investing in similar companies to SSI Strategy

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for SSI Strategy

4.2 - Public trading comparable groups for SSI Strategy

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to SSI Strategy

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About SSI Strategy

What does SSI Strategy do?

SSI Strategy is a provider of life sciences consulting combining business, medical, clinical, and pharmacovigilance expertise across the product lifecycle, including pre-clinical target identification, regulatory compliance, toxicology and FIH preparation; early development infrastructure and teams; late-stage evidence for regulatory approval, payer acceptance and patient outcomes; commercialization (launch and post-market support); and AI solutions via Metalmind.

Who are SSI Strategy's competitors?

SSI Strategy's competitors and similar companies include Minafin, Orgenesis, Build Clinical, Project Farma, and Locust Walk.

Where is SSI Strategy headquartered?

SSI Strategy is headquartered in United States.

How many employees does SSI Strategy have?

SSI Strategy has 1,000 employees 🔒.

When was SSI Strategy founded?

SSI Strategy was founded in 2010 🔒.

What sector and industry vertical is SSI Strategy in?

SSI Strategy is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for SSI Strategy

Who are the top strategic acquirers in SSI Strategy's sector and industry

Top strategic M&A buyers and acquirers in SSI Strategy's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for SSI Strategy?

Top strategic M&A buyers groups and sectors for SSI Strategy include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in SSI Strategy's sector and industry vertical

Which are the top PE firms investing in SSI Strategy's sector and industry vertical?

Top PE firms investing in SSI Strategy's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in SSI Strategy's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in SSI Strategy's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in SSI Strategy's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to SSI Strategy include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in SSI Strategy's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for SSI Strategy?

The key public trading comparables and valuation benchmarks for SSI Strategy include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for SSI Strategy for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for SSI Strategy with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in SSI Strategy's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for SSI Strategy with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in SSI Strategy's' sector and industry vertical?

Access recent funding rounds and capital raises in SSI Strategy's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for SSI Strategy

Launch login modal Launch register modal